Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 3, 2016

View Archived Issues

Novartis reviews key milestones of fourth quarter 2015

Optogenetic modulation of response by controlling Ca2+ flow into cells: NIR-activated immunotherapy

Research Council of Norway awards funding to Bionor and Nordic Nanovector

Corvus initiates phase I/Ib study of CPI-444 in advanced cancer

Companies investigate approaches to tackle Zika virus

Shionogi updates progress of third quarter of fiscal 2015

Targovax submits a study protocol for ONCOS-102 trial to the regulatory authorities in Spain

AbbVie updates pipeline progress of fourth quarter 2015

The Medicines Company completes divestiture of hemostasis portfolio to Mallinckrodt

Recurrent genetic alterations identified in low-grade neuroepithelial tumors

Ligand licenses use of OmniAb platform to Tizona Therapeutics

Endomorphin analogues show potent analgesia with low side-effect profile

Repurposing RXR agonist HX-630: Possible new treatment for Cushing's disease?

Abbott to acquire Alere

Ono Pharmaceutical recaps highlights of third quarter of fiscal 2015

Neurocrine initiates phase II study of valbenazine in pediatric patients with Tourette syndrome

LEO Pharma and arGEN-X select cell line for manufacture of antibody against skin inflammation

Trimesta shows no benefit in relapsing-remitting MS in women

Versartis reports results from extension study of somavaratan in children with GHD

FDA issues CRL regarding Telesta Therapeutics' MCNA

Tagrisso approved in E.U. for EGFR-mutant NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...